Clinical Trial Update: Ancillary Study of Methylation Biomarkers in a Randomized Controlled Trial of a Personalized Prevention of Colorectal Cancer [NA]

View source ↗

Summary

An ancillary methylation biomarker study within a randomized, personalized colorectal cancer prevention trial has completed and posted its results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Colorectal Cancer | NA | Status: COMPLETED | Results posted: 2024-06-25